Characterised autologous human cartilage cells 4million cells/0.4ml implantation suspension vials

in short Human cartilage cells 4million cells/0.4ml imp vials

previously Autologous human cartilage cells 4million cells/0.4ml implantation suspension vials

SNOMED code
16615111000001104
Named
Active compound
Characterised autologous human cartilage cells
Preferred name basis
Other
previously
Other
Prescribable
✅ Yes
Non-availability
Actual Products not Available
Non-availability date
Dose form
Discrete
Dose size and units
0.4 ml, vial
Ingredients
Characterised autologous human cartilage cells — 10000 Cell / 1 microlitre based on ingredient substance
Form & Route
implantationsuspension.intralesional
Implantation suspension, Intralesional
Controlled drug
No Controlled Drug Status

Products

ChondroCelect 4million cells/0.4ml implantation suspension vials (Swedish Orphan Biovitrum Ltd)

in short ChrondroCelect 4million cells/0.4ml imp vials

ChondroCelect 4million cells/0.4ml implantation suspension vials

SNOMED code
16615311000001102
Supplier
Swedish Orphan Biovitrum Ltd
Licensed as
Medicines - MHRA/EMA
Availability restrictions
Not available
Licensed route
Intralesional
Pack name & codeStatusGTIN, EAN barcodesPricePrescribingReimbursementPack
ChondroCelect 4million cells/0.4ml implantation suspension vials (Swedish Orphan Biovitrum Ltd) 1 vial
16615411000001109   ref. pack
Discontinued


Legal category: POM
No Price Available
 
previously: £18,301
• Hospital
  • • Prescription Charges

Reference packs

Characterised autologous human cartilage cells 4million cells/0.4ml implantation suspension vials 1 vial
SNOMED code
16615211000001105
Quantity and unit
1 vial
Packs